MIG Capital LLC lowered its holdings in shares of Sotera Health (NASDAQ:SHC – Free Report) by 0.4% during the second quarter, Holdings Channel reports. The firm owned 3,656,473 shares of the company’s stock after selling 15,935 shares during the period. Sotera Health accounts for about 12.5% of MIG Capital LLC’s portfolio, making the stock its largest position. MIG Capital LLC’s holdings in Sotera Health were worth $68,888,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. William Blair Investment Management LLC lifted its holdings in Sotera Health by 10.5% in the 2nd quarter. William Blair Investment Management LLC now owns 1,961,646 shares of the company’s stock worth $36,957,000 after purchasing an additional 185,883 shares during the last quarter. ExodusPoint Capital Management LP acquired a new stake in shares of Sotera Health in the second quarter worth $435,000. Osaic Holdings Inc. grew its stake in Sotera Health by 100.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,549 shares of the company’s stock valued at $48,000 after buying an additional 1,279 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Sotera Health by 56.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,230,323 shares of the company’s stock valued at $23,181,000 after buying an additional 446,046 shares during the last quarter. Finally, TD Asset Management Inc acquired a new position in Sotera Health during the 2nd quarter worth $313,000. Institutional investors and hedge funds own 88.89% of the company’s stock.
Analysts Set New Price Targets
SHC has been the topic of several research analyst reports. Royal Bank of Canada lowered their price target on Sotera Health from $22.00 to $20.00 and set an “outperform” rating on the stock in a research report on Thursday, November 2nd. KeyCorp reduced their price objective on Sotera Health from $24.00 to $23.00 and set an “overweight” rating for the company in a research report on Friday, August 4th. Finally, Barclays cut their target price on shares of Sotera Health from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Thursday, November 2nd. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.17.
Sotera Health Stock Performance
Shares of NASDAQ SHC traded down $0.12 during trading hours on Tuesday, reaching $13.81. The stock had a trading volume of 41,222 shares, compared to its average volume of 1,309,091. The company has a market cap of $3.90 billion, a price-to-earnings ratio of -12.66 and a beta of 2.26. Sotera Health has a twelve month low of $7.66 and a twelve month high of $19.40. The business’s fifty day moving average is $13.97 and its two-hundred day moving average is $15.59. The company has a debt-to-equity ratio of 6.06, a current ratio of 2.59 and a quick ratio of 2.40.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services.
- Five stocks we like better than Sotera Health
- What is the S&P/TSX Index?
- Zoom Video Communications: A tech phoenix ready to rise
- Insider Trades May Not Tell You What You Think
- The only two airline stocks worth buying: One is a Goldman pick
- Dividend Tax Calculator
- Ride the momentum: Apparel stocks soaring at 52-week highs
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.